Effectiveness of Antrodia Cinnamomea Mycelia on Improving Immune Response in Subhealth People
NCT ID: NCT05728918
Last Updated: 2024-08-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
25 participants
INTERVENTIONAL
2023-03-01
2024-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Anti-hypertensive Effect of Mycelia of Antrodia Cinnamomea
NCT02532699
The Effects of Traditional Herbal Dietary Supplements on General Fatigue and Negative Emotions of Graduate Students
NCT05724238
Can Rhodiola Crenulata Intake Improve Oxygen Saturation and Decrease the Incidence of Acute Mountain Sickness
NCT01536288
Modulation of Immunity-related Gene Expression Under the Chinese Herbal Formula SS-1 Treatment for Sjögren's Syndrome
NCT02855658
Nettle and Cranberry Capsules for Prevention of Urinary Tract Infection
NCT05880602
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo
Placeo group
Placebo
Placebo capsule, two capsules/day (600 mg/day) for 3 months
Treatment
Experimental group
Antrodia cinnamomea mycelia
Antrodia cinnamomea mycelia capsule, two capsules/day (600 mg/day) for 3 months
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Antrodia cinnamomea mycelia
Antrodia cinnamomea mycelia capsule, two capsules/day (600 mg/day) for 3 months
Placebo
Placebo capsule, two capsules/day (600 mg/day) for 3 months
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects have poor sleep quality
Exclusion Criteria
* Lactating women.
* Women gave birth 6 months before the study.
* Poor kindy and livers funcitons
* Severe cardiovascular or other chronic diseases
* Alcohol abuser
* Using immune-associated supplements
50 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Greenyn Biotechnology Co., Ltd.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ming-Shun Wu, MD
Role: PRINCIPAL_INVESTIGATOR
WanFang Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
WanFang Hospital
Taipei, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A-111-091
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.